| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | — | +68.6% |
| R&D Expense | $68.6M | — | -5.4% |
| SG&A Expense | $17.2M | — | -11.0% |
| Operating Income | -$130.2M | — | +12.2% |
| Interest Expense | $553K | — | — |
| Pre-tax Income | -$122.1M | — | +9.5% |
| Income Tax | $839K | — | -24.3% |
| Net Income | -$122.9M | — | +9.6% |
| EPS (Basic) | -$1.28 | — | +19.0% |
| EPS (Diluted) | -$1.28 | — | +19.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $423.3M | +21.8% | +80.0% |
| Short-term Investments | $2.02B | +24.0% | +24.6% |
| Current Assets | $2.45B | +23.3% | +31.1% |
| Total Assets | $2.73B | +20.3% | +25.8% |
| Current Liabilities | $136.3M | -8.6% | +14.1% |
| Long-term Debt | $585.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$108.9M | — | -101.9% |
| Capital Expenditures | $504K | — | +144.7% |
| Investing Cash Flow | -$410.7M | — | -1979.2% |
| Financing Cash Flow | $591.9M | — | +5490.4% |
| Free Cash Flow | -$109.4M | — | -102.0% |
| — |
| Total Liabilities | $911.3M | +165.3% | +170.5% |
| Stockholders' Equity | $1.81B | -5.6% | -0.8% |